BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2002
View Archived Issues
Schering-Plough presents 2001 annual report
Read More
Potent inhibitors of angiogenesis derived from thrombospondin-1
Read More
Cephalon designs new inhibitors of VEGF-dependent angiogenesis with good oral antitumor activity
Read More
Preliminary phase I results for ILX-651 discussed at AACR meeting
Read More
Preclinical characterization of Ro-31-7453, a new cell cycle inhibitor
Read More
SAR leading to TBC-3711, a potent, orally active, ETA-selective endothelin antagonist
Read More
Enrollment completed in phase II/III trial of Neurodex for emotional lability
Read More
Novartis presents data on the balanced NK1/NK2 antagonist DNK-333
Read More
Phase IB safety study of Moli-1901 in cystic fibrosis yields favorable results
Read More
Health Canada approves phase I/II Reolysin trial in patients with recurrent malignant glioma
Read More
ChemGenex uses chemical genomics to advance experimental anticancer drugs
Read More
Affitech acquires exclusive worldwide license for Troybodies technology
Read More
GW expands phase III program for cannabis-based medicines
Read More
Phase I/II results for WX-G250 in metastatic RCC indicate clinical benefit and good tolerance
Read More
Alliance for research on interferon gamma-1b for asthma
Read More
HE-2200 for potentiating impaired immune systems
Read More
Inhibitors of Src tyrosine kinases reported by AstraZeneca
Read More
Pharmacodynamic and pharmacokinetic effects of renzapride examined in IBS
Read More
Collaboration to identify single-chain antibody therapeutics
Read More
FDA concerns will delay Ariza marketing
Read More
Calcium receptor antagonists especially useful in osteoporosis according to JT
Read More
Agouron designs new series with protein kinase-inhibitory and antitumor activity
Read More
Roche patents prodrugs of NMDA receptor antagonists
Read More
New MC4-selective agonists useful in obesity, etc.
Read More
Patent covers Genentech's new alpha4 integrin receptor ligands
Read More